INTRAGEL THERAPEUTICS - UROGEN RECEIVES EXCLUSIVE OPTION FOR WORLDWIDE LICENSE TO DEVELOP AND COMMERCIALIZE TUMOCURE

Reuters · 1d ago

Please log in to view news